Cell and Gene Therapy Pricing and Reimbursement Summit

Topics

• Dissecting the Global Cell & Gene Landscape by Understanding the Current State & Address Critical Challenges to Improve Global Patient Access
• Evaluating Value-Based Pricing to Amortize the Financial Burden & Support Manufacturer’s Profitability
• Tackling Health Economics & Real-World Evidence to Establish a Robust Delivery Model for Expediting Approvals of Transformative Therapies
• Navigating the Complexities of Real-Wold Evidence by Addressing Patient Enrollment & Data Collection for Increased Access
• Reviewing One-Time Payment Mechanisms to Address the Misalignment with the Current Pay-for-Service Model to Improve Patient Access
• Exploring Reimbursement Strategies for High-Cost Therapies to Promote Standardization & Roll Out Therapies Quicker
• Exploring Successful Strategies for Launching Therapies in a Dynamic Market by Delving into Early-Stage Commercial Strategy, Market Insights & Regulatory Policy